MONMOUTH JUNCTION, N.J., July 19, 2018 /PRNewswire/ — DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that it will exhibit at the Alzheimer’s Association International Conference to be held in Chicago, ILon July 22-26, 2018. At the DiamiR booth, #713 in Hall F1 of McCormick Place, the company staff will meet with the conference attendees to discuss DiamiR’s targeted approach to early detection, differential diagnosis, and monitoring of neurodegenerative diseases based on the quantitative analysis of brain-enriched microRNAs circulating in plasma. Dr. Kira Sheinerman, Chief Executive Officer, and Jennifer Seibert, Strategic Development, will provide updates on the ongoing and planned projects and discuss collaborative opportunities.